Description of the Business, Basis of Presentation and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Dec. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Loss Per Common Share (Details - Schedule of Antidilutive Securities)

	December 31,
	2023		2022
Equity based warrants to purchase common shares		5,914,929		6,569,929
Convertible Notes - common shares (1)		1,000,000		–
Convertible Notes - equity-based warrants to purchase common shares		500,000		–
Termination agreement - equity-based warrants to purchase common shares (2)		1,600,000		–
Stock options granted under Company's incentive plan		1,703,600		–
Total potentially dilutive securities		10,718,529		6,569,929